# NEWS UPDATED!

Our official webpage is currently down. =(

please read here.


Check out EMAN's official website here! =)


2009-11-18

PECIPTA 2009 : SILVER MEDAL

CONGRATULATIONS !!!





CONGRATULATIONS to Dr. Amin Malik Shah Abdul Majid, Hayder B. Sahib, Prof. Zahri Ismail, Dr. Salizawati M. Salhimi, Dr. Zaini Asmawi, M. Jamshed Siddiqui, and Khalid Hussin. Of course, not forgetting, Abdalrahim F.A. Aisha, Saleh Mustafa Al-Omari, and Norshirin Idris. 

The team won silver for product , Canssufive which is an inhibitor of angiogenesis and enhancer of Tamoxifen activity.

PECIPTA 2009 was held at KLCC on 8-10 October 2009 and was organized by Universiti Malaya. It was an annual  high profile Malaysia research exhibition where participants come from institutions of higher learning inside and outside of Malaysia.

2009-11-01

AbdalRahim F. A. Aisha






A Lil Bit About Me:

Abdalrahim was born and grew up in small village near Nablus city of Palestine. His Bachelor’s degree was in Medical Laboratory Analysis in 1997 and his Master’s degree was in Biological Sciences in 2002 and both were obtained from An Najah National University of Palestine. He was working six years from 2002 to 2008 as a teacher in governmental section in Palestine. Since June 2008 he is enrolled in PhD programme at Department of Pharmacology, School of Pharmaceutical Sciences, USM. His research area is cancer therapeutics from natural products and especially from medicinal plants. His principal goal is to find a potent and coast effective anticancer drug from medicinal plants. He realized that a researcher life is his life and so he devoted most of his time for his research. He likes cooking especially Barbeque. Here he enjoys the beautiful nature of Malaysia with his beloved wife and his daughters Marah and Jana.

Research interests:

I'm interested in studying the anti-angiogenic activity of low molecular weight natural products for the treatment of different kinds of cancer. Besides that, I’m also want to explore the potential of natural products that I selected as anti-androgens and anti-estrogens for the treatment of both prostrate and breast cancers respectively.